Laura L. Douglass is Director at LA JOLLA PHARMACEUTICAL CO (LJPC). They have made 1 open-market trade across 1 company since 2017, most recently 2018-05-30.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LJPC | 500 | $3K |
Shares reported on the most recent Form 4, priced at the 2018-06-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LJPC | SELL | 2017-12-29 | 2018-01-03 | $32.32 | $323K | -15.6% | +14.2% | -10.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.